Scripps, City of Hope Team Up to Find New Treatment for HIV
April 25, 2017 | by Michael Easterling
The new technique offers a significant advantage over therapies where antibodies float freely in the bloodstream at a relatively low concentration. Instead, antibodies in the new study “hang on” to a cell’s surface, blocking HIV from accessing a crucial cell receptor and spreading infection.
Essentially the researchers are forcing cells to compete in a Darwinian “survival-of-the-fittest” match. Cells without antibody protection die off, leaving protected cells to survive and multiply, and pass along the protective gene to new cells.
“We currently have active clinical trials of gene therapy for AIDS using blood stem cell transplantation, and this experience will be applied to the task of bringing this discovery to the clinic,” said John A. Zaia, M.D., the Aaron D. Miller and Edith Miller Chair in Gene Therapy. “We’re committed to helping the Scripps scientists do the work to translate this research as quickly as we can into a usable therapy we can connect patients to. Our focus and ultimate goal will be the control of HIV in patients with AIDS without the need for other medications.”
TSRI’s Richard Lerner, M.D., the study’s senior author, said that City of Hope is the ideal place to advance this research. “It’s an honor to collaborate with physicians and scientists at City of Hope, whose expertise in transplantation in HIV patients should hopefully allow this therapy to one day be used in patients.”
Joseph Alvarnas, M.D. City of Hope’s director of value based analytics, said he believes this research is particularly important because people with HIV still have a high risk of cancer even if they are on anti-retroviral treatments.
“HIV remains a disease that causes a lot of suffering,” Alvarnas said. “That makes the case for why these technologies are so important.”
, Thank you for supporting our mission of eliminating cancer and other life-threatening diseases! Make sure to check your inbox from time to time for the latest City of Hope updates and breakthroughs.
You may also be interested in
Autologous stem cell transplantation offers safe and effective, and potentially curative, option for patients with HIV-associated lymphoma
Combination Immunotherapy Shown to Be Effective Initial Treatment for Relapsed or Refractory Hodgkin Lymphoma